APHINITY trial (BIG 4-11): A randomized comparison of chemotherapy (C) plus trastuzumab (T) plus placebo (Pla) versus chemotherapy plus trastuzumab (T) plus pertuzumab (P) as adjuvant therapy in patients (pts) with HER2-positive early breast cancer (EBC) Meeting Abstract
| Authors: | Von Minckwitz, G.; Procter, M. J.; De Azambuja, E.; Zardavas, D.; Knott, A.; Viale, G.; Suter, T. M.; Arahmani, A.; Rouchet, N.; Clark, E.; Benyunes, M.; Lang, I.; Levy, C.; Yardley, D. A.; Bines, J.; Gelber, R. D.; Piccart-Gebhart, M. J.; Baselga, J. |
| Abstract Title: | APHINITY trial (BIG 4-11): A randomized comparison of chemotherapy (C) plus trastuzumab (T) plus placebo (Pla) versus chemotherapy plus trastuzumab (T) plus pertuzumab (P) as adjuvant therapy in patients (pts) with HER2-positive early breast cancer (EBC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-06-20 |
| Language: | English |
| ACCESSION: | WOS:000456827200007 |
| DOI: | 10.1200/JCO.2017.35.18_suppl.LBA500 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA500 -- Source: Wos |
